Jamal Ouazzani

Dr. Jamal Ouazzani

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JMJean-Luc Mainardi
Jean-Luc Mainardi
MFMartine Fourgeaud
Martine Fourgeaud
JHJean-Emmanuel Hugonnet
Jean-Emmanuel Hugonnet
LDLionel Dubost
Lionel Dubost
JBJean-Paul Brouard
Jean-Paul Brouard
MAMichel Arthur
Michel Arthur
The β-lactam antibiotics remain the most commonly used to treat severe infections. Because of structural similarity between the β-lactam ring and the d-alanyl4-d-alanine5 extremity of bacterial cell wall precursors, the drugs act as suicide substrates of the dd-transpeptidases that catalyze the last cross-linking step of cell wall assembly. Here, we show that this mechanism of action can be defeated by a novel type of transpeptidase identified for the first time by reverse genetics in aβ-lactam-resistant mutant of Enterococcus faecium. The enzyme, Ldtfm, catalyzes in vitro the cross-linking of peptidoglycan subunits in a β-lactam-insensitive ld-transpeptidation reaction. The specificity of Ldtfm for the l-lysyl3-d-alanine4 peptide bond of tetrapeptide donors accounts for resistance because the substrate does not mimic β-lactams in contrast to d-alanyl4-d-alanine5 in the pentapeptide donors required for dd-transpeptidation. Ldtfm homologues are encountered sporadically among taxonomically distant bacteria, indicating that ld-transpeptidase-mediated resistance may emerge in various pathogens.

1 December 2014 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
GGGéraldine Le Goff
Géraldine Le Goff
JOJamal Ouazzani
Jamal Ouazzani

9 September 2008 in Proteomics
Verified
Journal Article
Closed access
PDF file
DDDelphine Debois
Delphine Debois
KHKassem Hamze
Kassem Hamze
VGVincent Guérineau
Vincent Guérineau
JCJean‐Pierre Le Caër
Jean‐Pierre Le Caër
IHI. Barry Holland
I. Barry Holland
OLOlivier Laprévote
Olivier Laprévote

1 January 2014 in Phytochemistry
Verified
Journal Article
Closed access
EAEmilie Adelin
Emilie Adelin
CSClaudine Servy
Claudine Servy
MMMarie-Thérèse Martin
Marie-Thérèse Martin
GAGuillaume Arcile
Guillaume Arcile
BIBogdan Iorga
Bogdan Iorga
JOJamal Ouazzani
Jamal Ouazzani

1 March 1999 in Chemosphere
Verified
Journal Article
Closed access
LCLaurence Le Campion
Laurence Le Campion
CGCharles Giannotti
Charles Giannotti
JOJamal Ouazzani
Jamal Ouazzani

21 October 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
DTDong-Song Tian
Dong-Song Tian
EKEric Kuhnert
Eric Kuhnert
JOJamal Ouazzani
Jamal Ouazzani
DWDaniel Wibberg
Daniel Wibberg
JKJörn Kalinowski
Jörn Kalinowski
RCRussell Cox
Russell Cox
The biosynthetic gene cluster of the antifungal metabolite sporothriolide 1 was identified from three producing ascomycetes: Hypomontagnella monticulosa MUCL 54604, H. spongiphila CLL 205 and H. submonticulosa DAOMC 242471. A transformation protocol was established, and genes encoding a fatty acid synthase subunit and a citrate synthase were simultaneously knocked out which led to loss of sporothriolide and sporochartine production. In vitro reactions showed that the sporochartines are derived from non-enzymatic Diels–Alder cycloaddition of 1 and trienylfuranol A 7 during the fermentation and extraction process. Heterologous expression of the spo genes in Aspergillus oryzae then led to the production of intermediates and shunts and delineation of a new fungal biosynthetic pathway originating in fatty acid biosynthesis. Finally, a hydrolase was revealed by in vitro studies likely contributing towards self-resistance of the producer organism.